O-106 A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)
- 31 July 2005
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 49, S38-38
- https://doi.org/10.1016/s0169-5002(05)80240-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: